| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8707125 | Oral Oncology | 2018 | 6 Pages |
Abstract
The combination of nab-paclitaxel, CbP and C225 is feasible, tolerable and active against locally advanced SCCHN.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Jared Weiss, Jill Gilbert, Allison Mary Deal, Mark Weissler, Chris Hilliard, Bhishamjit Chera, Barbara Murphy, Trevor Hackman, Jay Justin Liao, Juneko Grilley Olson, David Neil Hayes,